Barbara Hartz

Title: Barbara Hartz - Innovator in Benzothiazine Derivatives

Introduction

Barbara Hartz is a notable inventor based in Ballerup, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzothiazine derivatives. Her research focuses on compounds that have the potential to modulate AMPA sensitive glutamate receptors, which are crucial in various therapeutic applications.

Latest Patents

Barbara Hartz holds a patent for her invention titled "Benzothiazine derivatives, their preparation and use." This patent describes novel benzothiazine derivatives of Formula I that are useful as modulators of the AMPA sensitive glutamate receptors. The pharmaceutical compositions comprising these compounds have promising applications in therapy, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Barbara has been associated with Neurosearch A/S, a company dedicated to developing innovative treatments for neurological disorders. Her work at Neurosearch A/S has allowed her to explore the therapeutic potential of her inventions and contribute to the advancement of pharmaceutical research.

Collaborations

Barbara has collaborated with esteemed colleagues, including Alex Haahr Gouliaev and Morgens Larsen. These partnerships have enriched her research and fostered a collaborative environment that encourages innovation.

Conclusion

Barbara Hartz is a pioneering inventor whose work on benzothiazine derivatives has the potential to impact therapeutic practices significantly. Her dedication to research and collaboration exemplifies the spirit of innovation in the pharmaceutical industry.